1/12/2024 | BK | Market Commentary: WEX, BRP, Dealer Tire, SolarWinds, Jane Street, Signature Aviation, Jeld-Wen, Jones break
|
1/8/2024 | BK | Market Commentary: Zelis, Clarios tweak deals; Inspire, Citadel, Caliber, Jane, DirecTV and more set talk
|
1/8/2024 | CLHY | Market Commentary: Zelis, Clarios tweak deals; Inspire, Citadel, Caliber, Jane, DirecTV and more set talk
|
1/8/2024 | BK | Jazz Pharmaceuticals launches $2.72 billion loan at SOFR plus 300 bps
|
4/14/2016 | PP | Market Commentary: Priceline 1% convertibles add with shares; Energy XXI files for bankruptcy; SunEdison up
|
4/14/2016 | CV | Market Commentary: Priceline 1% convertibles add with shares; Energy XXI files for bankruptcy; SunEdison up
|
3/27/2015 | PP | Market Commentary: BioMarin As gain on swap, BioMarin Bs in line amid takeout rumors; health care better bid
|
3/27/2015 | CV | Market Commentary: BioMarin As gain on swap, BioMarin Bs in line amid takeout rumors; health care better bid
|
2/19/2015 | PP | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
2/19/2015 | CV | Market Commentary: Health care names weaker after Actavis launches large mandatory; Priceline slightly better
|
12/31/2014 | CV | Market Commentary: Outlook 2015: U.S. convertibles primary notches multi-year high; volume expected to climb
|
8/8/2014 | PP | Market Commentary: Jazz Pharmaceuticals deal prices, trades actively; Synchronoss new issue slips slightly
|
8/8/2014 | CV | Market Commentary: Jazz Pharmaceuticals deal prices, trades actively; Synchronoss new issue slips slightly
|
8/8/2014 | CV | Market Commentary: Morning Commentary: Jazz Pharmaceuticals prices new deal, trades actively; Synchronoss steady
|
8/7/2014 | BKCV | Moody’s upgrades Jazz Pharmaceuticals
|
1/24/2014 | BK | Market Commentary: Verint, W.R. Grace, Mitel, First Data, Connolly, Viskase, Endeavour break; DAE shutting early
|
1/23/2014 | BK | Market Commentary: JLL/Delta, PharMEDium, Dixie, West, Axalta, Jazz free to trade; Avaya gains with repricing
|
1/21/2014 | BK | Jazz Pharmaceuticals reworks incremental loan sizes, adds repricing
|
1/21/2014 | BK | Market Commentary: First Data, Jazz trade lower; Dematic, SeaStar break; PharMEDium, AlixPartners update deals
|
1/7/2014 | BK | Jazz Pharmaceuticals sets talk on $575 million of loans with launch
|
1/7/2014 | BK | Market Commentary: Univision dips on repricing; CBS Outdoor, Mitel, Jazz, Endeavour, Houghton, Epicor set talk
|
1/3/2014 | BK | Jazz Pharmaceuticals to launch $575 million of loans on Tuesday
|
1/3/2014 | BK | Market Commentary: Chrysler dips with sales results; Jazz Pharma, Mitel, CBS Outdoor, Viskase set launches
|
6/13/2013 | BK | Market Commentary: Rite Aid, Weather tweak deals, break; Harvey Gulf, CTI Foods reworked; Yankee Candle pulled
|
6/7/2013 | BK | Jazz Pharmaceuticals sets $557 million term loan at Libor plus 275 bps
|
6/7/2013 | BK | Market Commentary: Jazz Pharma, Allflex, InterGen, Pre-Paid Legal, ValleyCrest, Auxilium, TeleGuam free up
|
5/29/2013 | BK | Jazz Pharmaceuticals sets talk on $757 million facility with launch
|
5/29/2013 | BK | Market Commentary: NRG, StoneRiver, School Specialty, Grande Communications break; Summit Business updates deal
|
5/28/2013 | BK | Jazz Pharmaceuticals to launch $757 million facility on Wednesday
|
5/28/2013 | BK | Market Commentary: US Foods, Clondalkin break; Guitar Center up with amendment launch; YP, Alliance tweak deals
|
5/15/2012 | BK | Moody's rates Jazz loans Ba3
|
6/30/2010 | LMPPPV | Jazz Pharmaceuticals prepays all $63.5 million of remaining 15% notes
|
11/23/2009 | PP | New Issue: Jazz revises $75 million equity financing facility with Kingsbridge
|
11/10/2009 | PV | Jazz Pharmaceuticals subsidiary to amortize $40 million of notes
|
7/7/2009 | DDPPPV | Jazz Pharmaceuticals makes $14.6 million interest payments on notes
|
7/7/2009 | PP | New Issue: Jazz Pharmaceuticals negotiates $7 million private placement of units
|
7/7/2009 | PP | Market Commentary: Cord Blood arranges long-term investment; Somaxon plans stock sale; Jazz to sell equity units
|
1/12/2009 | DDPP | Jazz Pharmaceuticals misses interest payment on 15% notes, gets default notice
|
12/31/2008 | PP | Outlook 2009: Market shrinks in 2008, outlook hazy; private equity, preferreds could play bigger role
|
7/16/2008 | PP | New Issue: Jazz prices $26 million direct offering of units
|
6/11/2008 | CVHY | Jazz files $100 million shelf registration
|
5/8/2008 | PP | New Issue: Jazz negotiates $75 million equity financing facility with Kingsbridge
|
5/8/2008 | PP | Market Commentary: Jazz keeps options open with deal; ROO, Microfield issue stock and warrants; Western Standard sells stock
|
3/18/2008 | PP | New Issue: JPI completes $40 million senior secured notes sale
|
9/7/2006 | BT | Jazz Pharmaceuticals starts phase 3 trial of Xyrem in fibromyalgia
|